SUBSCRIBE
SUBSCRIBE

Sage Therapeutics

Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
MA Startup SAGE Therapeutics’ Drug For Rare Epilepsy Shows Promise In Small Study
November 10, 2014
 · 
3 min read
Load More
AWARDS
  • 2024 Best Places to Work
  • 2022 Best Places to Work
JOBS
IN THE PRESS
Genetown
Sage Therapeutics to Present at BMO 2020 Growth & ESG Conference
December 3, 2020
 · 
1 min read
Business
Biogen and Sage Therapeutics Announce Global Collaboration to Develop and Commercialize Potential Breakthrough Therapies in Depression and Movement Disorders
November 27, 2020
 · 
16 min read
Business
Sage Therapeutics Announces Third Quarter 2020 Financial Results and Highlights Pipeline and Business Progress
November 5, 2020
 · 
19 min read
Genetown
Sage Therapeutics to Present at Upcoming November 2020 Investor Conferences
November 2, 2020
 · 
1 min read
Business
Sage Therapeutics Announces Chief Executive Jeff Jonas to Undergo Scheduled Medical Procedure
October 22, 2020
 · 
1 min read
Business
Sage Therapeutics to Report Third Quarter 2020 Financial Results on Thursday, November 5, 2020
October 19, 2020
 · 
1 min read
Drug Development
Sage Therapeutics Announces Positive Interim, Topline Zuranolone Safety and Tolerability Data from Open-Label SHORELINE Study in Patients with MDD
October 15, 2020
 · 
11 min read
Business
Sage Therapeutics Appoints Barry Greene to Board of Directors
October 1, 2020
 · 
3 min read
Genetown
Sage Therapeutics’ FutureCast to Provide Update on Pipeline Progression and Additional Insights into Potential of Brain Health Franchises
September 10, 2020
 · 
6 min read
Genetown
Sage Therapeutics to Present at Morgan Stanley 18th Annual Global Healthcare Conference
September 1, 2020
 · 
1 min read
Load More